Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy

被引：0

作者：

Saitoh, A

Suzuki, Y

Takeda, M

Kubota, K

Itoh, K

Tomino, Y

机构：

[1] Juntendo Univ, Sch Med, Dept Med, Div Nephrol,Bunkyo Ku, Tokyo 113, Japan

[2] Special Reference Lab, Tokyo, Japan

[3] Kanagawa Prefectural Coll Nursing & Med Technol, Kanagawa, Japan

来源：

JOURNAL OF CLINICAL LABORATORY ANALYSIS | 1998年 / 12卷 / 01期

关键词：

MCP-1; ELISA; urine; renal histology; IgA nephropathy;

D O I：

10.1002/(SICI)1098-2825(1998)12:1<1::AID-JCLA1>3.0.CO;2-F

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Using a quantitative sandwich ELISA, we studied 17 patients with IgA nephropathy to determine if levels of urinary monocyte chemoattractant protein-1 (MCP-1) might reflect the disease activity. The levels of urinary MCP-1 in patients with the advanced stage were significantly higher than those in patients with the mild stage of the disease, or in healthy controls. The results showed a significant correlation between the levels of urinary MCP-1 and the disease activity, i.e., levels of urinary casts and urinary protein. It was thus suggested that the measurement of urinary MCP-1 is useful in evaluating the degree of renal invanced juries and/or prognosis in patients with IgA nephropathy. (C) 1998 Wiley-Liss, Inc.

引用

页码：1 / 5

页数：5

共 50 条

[11] Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis
Marks, Stephen D.
Shah, Vanita
Pilkington, Clarissa
Tullus, Kjell
PEDIATRIC NEPHROLOGY, 2010, 25 (11) : 2283 - 2288
[12] Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease
Jibiki, T
Terai, M
Shima, M
Ogawa, A
Hamada, H
Kanazawa, M
Yamamoto, S
Oana, S
Kohno, Y
ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : 2211 - 2212
[13] Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1α (MIP-1α) levels with disease activity and clinical course of sarcoidosis
Hashimoto, S
Nakayama, T
Gon, Y
Hata, N
Koura, T
Maruoka, S
Matsumoto, K
Hayashi, S
Abe, Y
Horie, T
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 111 (03): : 604 - 610
[14] URINARY LEVELS OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) PREDICT THE SEVERITY OF SYMPTOM AND RESPONSE TO TREATMENT IN PATIENTS WITH OVERACTIVE BLADDER (OAB)
Ghoniem, Gamal
Farhan, Bilal
Ahmed, Ahmed
Zaldivar, Frank
NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S524 - S524
[15] URINARY LEVELS OF INTERLEUKIN-6 AND DISEASE-ACTIVITY IN PATIENTS WITH IGA NEPHROPATHY
TOMINO, Y
FUNABIKI, K
OHMURO, H
SHIMIZU, M
YOKOYAMA, K
SHIRATO, I
SHIRAI, T
TAKAHASHI, M
KOIDE, H
AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (06) : 459 - 464
[16] Levels of urinary complement factor H in patients with IGA nephropathy correlate with disease activity
Zhang, Jun-Jun
Jiang, Lei
Liu, Gang
Wang, Su-Xia
Zou, Wan-Zhong
Zhang, Hong
Zhao, Ming-Hui
Wang, Hai-Yan
NEPHROLOGY, 2008, 13 : A10 - A10
[17] Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis
Tam, FWK
Sanders, JS
Abraham, GE
Hammad, T
Miller, C
Dougan, T
Cook, HT
Kallenberg, CGM
Gaskin, G
Levy, JB
Pusey, CD
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) : 2761 - 2768
[18] Effects of losartan on expression of monocyte chemoattractant protein-1 ( MCP-1) in hyperuricemic nephropathy rats
Yu, Shengyou
Ren, Qi
Wu, Wei
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2015, 35 (05) : 458 - 461
[19] MONOCYTE CHEMOATTRACTANT PROTEIN (MCP)-1 IS REQUIRED FOR LIVER REGENERATION
Hennings, D. L.
Mitchell, K.
JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (01) : 219 - 219
[20] In rheumatoid arthritis monocyte-chemoattractant protein 1 (MCP-1) is a new marker of disease activity.
Ellingsen, T
Buus, A
Stengaard-Pedersen, K
ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S311 - S311

← 1 2 3 4 5 →